New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) will be conducting a review of ...

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or ...

Fear, withdrawal symptoms, and a lack of professional support are common barriers to detoxification from opioid substitution ...

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...

Dr Daskalakis explains revisions to the government budget rules that could have long-term impacts on scientific funding.

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention ...

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild ...

Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...

Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.